1. Osteoporosis: A Therapeutic Update
Patricia A. Mackey, FNP-BC, BC-ADM, Michael D. Whitaker, MD, FRCPC 
The Journal for Nurse Practitioners 
Volume 11, Issue 10, Pages (November 2015)
DOI: /j.nurpra
Copyright © 2015 Elsevier Inc. Terms and Conditions

2. Figure 1
Bone remodeling cycle. Points of therapeutic intervention include preventing osteoclast function (Antiresorptive Rx) or enhancing osteoblast action (Anabolic Rx).
The Journal for Nurse Practitioners  , DOI: ( /j.nurpra )
Copyright © 2015 Elsevier Inc. Terms and Conditions

3. Figure 2
Bone density loss over time in postmenopausal women. The expected effect of antiresorptive therapy (Rx) is to stabilize bone density as inhibition of resorption ultimately leads to inhibition of formation. Formation-stimulating therapy (anabolic) should lead to further increases in bone density. Initiation of therapy sooner rather than later should predictably help prevent further loss and decrease the risk of fracture.
The Journal for Nurse Practitioners  , DOI: ( /j.nurpra )
Copyright © 2015 Elsevier Inc. Terms and Conditions